Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FS23A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,041
Award facts
- Contract value 100% obligated
- $11,040.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,040.77 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on December 24, 2025, with completion scheduled for December 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive award process. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. Mounjaro is a diabetes treatment medication, consistent with the company's extensive portfolio of pharmaceutical products supplied through its DLA contract vehicle. The competitive, non-set-aside nature of this award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements, and the firm fixed-price structure provides cost certainty for this specific medication delivery supporting the Defense Health Agency and related military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FS23A?
SPE2DR26FS23A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 24, 2025.
How much is contract SPE2DR26FS23A worth?
The government has obligated $11,041 on SPE2DR26FS23A.
Is contract SPE2DR26FS23A an order under another contract?
Yes. SPE2DR26FS23A is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS23A competed?
The extent of competition for SPE2DR26FS23A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award